ARCT Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.
$16.14 +0.40 (2.51%)
As of 07/01/2022 15:59:50 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Small cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 05/22/2013
Outstanding shares: 26,418,965
Average volume: 794,681
Market cap: $415,834,509
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: BKC9SX3
Valuation (See tab for details)
PE ratio: -2.15
PB ratio: 2.31
PS ratio: 26.87
Return on equity: -107.44%
Net income %: -1,282.61%